MedPath

A Study to Evaluate the Effect of Funk It Cycle Bites on PMS

Not Applicable
Completed
Conditions
Premenstrual Syndrome
Interventions
Other: Funk It Cycle Bites
Registration Number
NCT05900024
Lead Sponsor
Funk It Wellness
Brief Summary

This is a virtual, open-label, single-group study that will last 4 menstrual cycles. All participants will complete a questionnaire at the end of their first period after enrolling (baseline/non-intervention cycle 1), then proceed to take the product daily and complete questionnaires at the end of their next 3 periods (intervention cycles 1, 2, and 3). The study will involve 30 female participants with regular menstrual cycles who experience PMS.

Questionnaires will be used to monitor menstrual pain/cramps, energy levels, mood, and hormonal acne experienced before and during the menstrual cycle. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Female aged 18-40
  • Have a regular menstrual cycle (every 21-35 days).
  • Suffer from mild to moderate menstrual pain.
  • May experience mood swings and/or hormonal acne related to the menstrual cycle.
  • Otherwise generally healthy.
  • Willing to consume the test product with a ginger flavor.
  • Willing to refrain from taking any other supplements or prescription medications that may target the menstrual cycle or premenstrual syndrome (PMS) symptoms throughout the study period.
  • Willing and able to adhere to the study protocol, including taking supplements at the required times and completing questionnaires via the technology portal.
  • Able to communicate in English.
  • Participants must provide written informed consent (ICF).
Exclusion Criteria
  • Any unstable or uncontrolled medical or psychiatric illness.
  • Any uncontrolled chronic disease or condition that would prevent full participation in the study protocol.
  • A history of polycystic ovary syndrome (PCOS), endometriosis, premenstrual dysphoric disorder (PMDD), or undiagnosed vaginal bleeding.
  • Are taking hormonal contraception or exogenous sex hormones (estrogen, testosterone, progesterone), or have taken hormonal contraception or exogenous hormones in the past 6 months.
  • Are taking any prescription medication or supplements that target the menstrual cycle or PMS symptoms.
  • Are pregnant, breastfeeding, trying to become pregnant, or have been pregnant in the past 12 months.
  • Have any known severe allergic reactions, or any allergies of any severity to any of the test product's ingredients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cycle BitesFunk It Cycle BitesParticipants will consume 1 Cycle Bite per day.
Primary Outcome Measures
NameTimeMethod
Changes in pain levels, including menstrual cramps. [Time Frame: Baseline to Month 4]4 months

Survey-based assessment of acne using the Numerical Pain Rating Scale, a 0-10 point rating scale.

Changes in mood stability. [Time Frame: Baseline to Month 4]4 months

Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

Change in symptoms of premenstrual syndrome. [Time Frame: Baseline to Month 4]4 months

Survey-based assessment of symptoms using the Premenstrual Symptoms Screening Tool (PSST). Responses will be gathered using a 4-point Likert scale.

Changes in energy levels. [Time Frame: Baseline to Month 4]4 months

Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

Changes in acne. [Time Frame: Baseline to Month 4]4 months

Survey-based assessment of acne using the Acne Quality of Life (Acne-QOL) scale. Responses will be gathered using a 5-point Likert scale.

Secondary Outcome Measures
NameTimeMethod
Participant enjoyment of the product.4 months

Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

Trial Locations

Locations (1)

Citruslabs

🇺🇸

Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath